Medicare AdvantageCoverageMedium impact
MA07.032a, Tumor Treating Fields
Independence Blue Cross·Oncology, Radiation Oncology·Medical Policy
Effective date
Jan 1, 2026
We identified it
Jun 19, 2026
Summary
Policy MA07.032a regarding Tumor Treating Fields has been updated and is effective January 1, 2026. This is a recent Medicare Advantage policy change that may impact coverage, billing, or authorization requirements for tumor treating field therapy. Specific clinical details are not available in the provided summary.
Action Required
By December 15, 2025: Billing team must obtain and review the complete MA07.032a policy text from the source URL to identify specific billing codes, prior authorization requirements, and coverage criteria for tumor treating field services. Once details are confirmed, update billing system rules, encounter forms, and provider communication accordingly. Verify all Medicare Advantage claims for tumor treating fields comply with the updated policy effective 01/01/2026 to prevent denials.